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Background Outcomesreflecting the
social situation arewidelyconsidered as
important inthe treatmentof peoplewith
schizophrenia.
Aims To reviewconcepts of social
outcomesin schizophrenia and the
corresponding assessment instruments.
Method Non-systematic literature
review andreflection on conceptual and
methodological issues.
Results Concepts of social outcomes in
schizophrenia lack agreed definitions and
theoreticalmodels.A fundamental issue is
the distinction between objective and
subjective indicators.More researchhas
focused on subjective indicators, which
are onlyweaklycorrelatedwith objective
life situation and showconsistent
correlationswithmood.Various
assessment instruments have been
developedpragmatically, particularly to
measure qualityof life and social
functioning, and the literature provides
extensive data forcomparison.
Conclusions Established instruments
existtomeasure social outcomes in
schizophrenia.Their use requires an
awareness ofthe specific strengths and
limitations.
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Since the beginning of systematic outcome
assessment in schizophrenia in the 1960s,
there has been a wide consensus among
researchers and clinicians that capturing
psychopathological symptoms alone is not
sufficient to reflect relevant outcomes.
Particularly for evaluating long-term out-
comes, information on the social situation
of patients is regarded as essential. Social
outcomes assess how patients live, function
in society and perform their various roles.
Social outcomes are commonly used
throughout healthcare. Yet, there are some
specific reasons for their popularity in the
treatment of schizophrenia:
(a) The disorder is often persistent and
affects patients lifelong. Symptoms
and the associated distress may fluc-
tuate, and establishing symptoms at
any point in time might therefore yield
a less relevant picture than the more
stable social situation.
(b) Longitudinal research has shown that
antipsychotic medication can reduce pro-
ductive symptoms and prevent relapses
with subsequent re-hospitalisation.
Yet, this effect was not necessarily
linked with an improved social situa-
tion. Symptom improvement and
prevention of relapses alone do not
make patients necessarily more likely
to complete education, find employ-
ment and have social relationships.
These outcomes need therefore to be
assessed separately from symptoms.
(c) As a result of mental health reforms in
most high-income countries, the focus
of care has shifted from the asylum to
the community. Former long-term
hospitalised patients were discharged,
and there was an interest in how they
fared in the community without the
institutional protection of the asylum.
(d) Mental health reforms have been asso-
ciated with the formation of patient
organisations. Such organisations have
acquired an important voice in debates
on mental health policies and
commonly demand that social
outcomes are given more prominence
in both research and practice.
Other stakeholder groups often share
the perspective of patient organisations. In
public and professional debates on mental
healthcare, it is often felt that what really
matters is how patients live (e.g. whether
they do or do not have a job and friends)
rather than symptoms of illness.
IMPACTOF TREATMENT
ONSOCIALOUTCOMES
How can treatment of schizophrenia affect
social outcomes? There are at least three
possible mechanisms:
(a) Treatment can improve psychopatholo-
gical symptoms. A lower symptom
level can enable people with schizo-
phrenia to function and perform better
in their social context and subsequently
achieve more favourable social
outcomes.
(b) Treatment may have an impact not only
on conventional psychopathological
symptoms, but also on other cognitive
and social deficits that are illness
related, but are usually not captured
in psychopathological assessments (e.g.
the concept of social cognition, which
has received wide attention in the past
5 years). If treatment diminishes deficits
in social cognition, patients might be
more likely to establish and maintain
useful relationships and improve social
outcomes.
(c) Some care interventions focus directly
on social outcomes. For instance, voca-
tional rehabilitation programmes may
improve the work situation, and the
effect is not mediated by a reduction
of symptom levels or other illness-
related deficits.
Although the latter mechanism mainly
applies to a range of social management
interventions, the other mechanisms can
operate with all forms of psychological,
pharmacological and socio-therapeutic
treatments. In practice and research, the
mechanisms can be intertwined in a com-
plex way and are difficult to disentangle.
Yet, it may be concluded that social out-
comes can be used to assess the effects of
all forms of treatment in schizophrenia.
Because of the indirect nature of the po-
tential treatment effect on social outcomes,
they have been termed ‘distal’, as opposed
to the more ‘proximal’ outcome criterion
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of psychopathological symptoms (Watts &
Priebe, 2002). The effect on social out-
comes is less immediate than on symptoms,
and achieving improvements in a person’s
social situation usually takes time.
SOCIETALCONTEXT
AND CEILING EFFECTS
For the analysis of treatment effects on so-
cial outcomes, two fundamental issues
should be considered. One is the depen-
dency of social outcomes on the societal
context. For example, the likelihood of a
person with schizophrenia obtaining com-
petitive employment as a result of treat-
ment will heavily depend on societal
factors such as the general unemployment
rate and legislation for the employment of
people with disabilities. Thus, social out-
comes will rarely be a function of treatment
alone. Another issue when using social out-
comes for evaluating treatment is their dis-
tribution in the treated sample at baseline.
Psychopathological symptoms define the
illness and will always be at a considerable
level at the beginning of treatment, which
leaves room for improvement. To some ex-
tent, this also applied to social outcomes in
many studies when people with schizo-
phrenia were discharged after long-term
hospitalisation or began treatment in very
unfavourable circumstances. However,
there can be exceptions. It is possible that
people have symptoms of schizophrenia
but at the same time hold a respectable
and satisfactory social position and per-
form well in different societal roles. In such
a case, no treatment can improve the social
situation. At best it can help to maintain the
current level. Thus, unlike psychopatholo-
gical symptoms, treatment cannot always
aim to improve social outcomes, and
whether maintaining the given social situa-
tion can be rated a success is a difficult
question and depends on the quality of
the social situation before treatment.
CONCEPTSOF SOCIAL
OUTCOMES
Different concepts have been used to reflect
and summarise social outcomes in people
with schizophrenia. These include standard
of living, quality of life, social integration,
social adaptation, social functioning, social
integration, needs for care and, more re-
cently, social inclusion. None of these
concepts was introduced into psychiatry
on the basis of a theoretical model. If a
theoretical literature existed in psychology
and sociology – e.g. for the quality of life
concept – it was rarely considered when new
concepts were suggested and new assessment
tools were designed in psychiatry.
The reason for introducing a new con-
cept was commonly the intuitive appeal of
the term, which then led to efforts to find
definitions and, subsequently, develop cor-
responding assessment tools. There is no
universally accepted definition for any of
the concepts, and each can be used and
has been used in various ways, depending
on the perspective and interest of whoever
uses them. Since the 1980s researchers have
published definitions and taken a pragmatic
and often ad hoc approach to developing
operationalised methods for the assess-
ment. The operationalisation usually re-
quired some focus and narrowing down of
the various potential meanings of the con-
cepts. As a result, there is a tendency that
all assessment instruments for social con-
cepts lead to a disappointment in at least
some stakeholder groups because they do
not exactly reflect the specific or vague un-
derstanding of the concept in the given
group. To a different degree, this has hap-
pened whenever new concepts of social out-
comes have superseded previous concepts.
Books on quality of life and social function-
ing, the two dominating concepts, were
published in the 1990s (Tyrer & Casey
1993; Katschnig et al, 1997; Priebe et al,




Whatever concept is used in the assessment
of social outcomes, there are objective and
subjective indicators. Objective indicators
are facts about the social situation, which
– at least in theory – can be objectively
and unequivocally assessed. These include
whether a patient does or does not have
employment, a partner, independent ac-
commodation and social contacts. Such
‘hard’ outcomes are transparent, straight-
forward to interpret and of obvious rele-
vance. Out of all outcome criteria in
schizophrenia, they arguably have the high-
est appeal to the public and user organisa-
tions. If a treatment has a demonstrabable
positive effect on the employment of pa-
tients, to most stakeholders this will be
more persuasive of its value than an impact
on scales assessing symptoms or other
psychological constructs.
Objective indicators are important,
widely accepted and relatively easy to es-
tablish. Why is it then that they are not
more widely used and reported in studies
on the outcome of treatment in schizo-
phrenia? There are several reasons:
(a) Objective aspects of the social situation
are hard to influence and are very
‘distal’ outcome criteria. For example,
pharmaceutical companies might argue
that influencing the objective social
situation is too ambitious an aim for
treatment with antipsychotic medi-
cation, that demonstrating an impact
on the objective social situation would
take much longer than the usual
length of clinical trials, and that such
a criterion would be inappropriate
because pharmacological treatments
were developed to reduce symptoms,
not as ‘employment-finding’ drugs.
(b) Objective indicators tend to be difficult
to change. Even over longer periods
people with schizophrenia will not
easily move into competitive employ-
ment, find a partner and achieve inde-
pendent living. In a larger sample
some might improve on any one of
these criteria, but seldom on all. For
meaningful statistical testing of
changes over time, the different
aspects would have to be combined to
have a sufficient frequency of changes
and to avoid multiple testing. Interest-
ingly, such a combined measure of
objective indicators does not exist.
(c) Any outcome criterion may have
problems with floor and ceiling effects
but this applies particularly to hard
social outcomes. People who already
are in independent living and competi-
tive employment cannot improve any
more, so that these criteria become
meaningless as outcomes.
(d) Although objective indicators capture
hard facts and are usually straightfor-
ward to analyse, their interpretation
requires values, and these values can
vary depending on cultural back-
ground, social context and individual
perspectives. For example, for most
people being in employment is clearly
desirable, but how does one assess
social outcome in a person who does
not want to work and can afford
to live on other income? The depen-
dency of the assessment on values is
even more obvious with respect to
partnership and social contacts. People
s16
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might choose to live alone rather than
being forced into this as a result of
illness-related impairment. One solu-
tion to this dilemma is to ask patients
about their expectations and aspira-
tions, and relate their social situation
to their wishes. Following this
approach, social isolation would be a
negative outcome only if the person
would prefer to have more contacts.
This, however, goes beyond objective
indicators and introduces a subjective
dimension.
Subjective indicators comprise patient
ratings of feelings, thoughts and views on
their social situation. An appropriate de-
scription of the full range of social indica-
tors used in different concepts is beyond
the scope of this review, but it will focus
on quality of life, which is the most fre-
quently used concept in social outcomes in
the psychiatric literature.
QUALITYOF LIFE
Since the 1980s, quality of life has been in-
creasingly used as an outcome criterion in
psychiatric research. Commonly, objective
and subjective indicators are considered.
Lehman et al (1982) introduced a measure-
ment approach, which assesses personal
characteristics, objective indicators in dif-
ferent domains of life and subjective quality
of life in the same life domains. Subjective
quality of life represents the person’s ap-
praisal of their objective life conditions,
mostly captured by rating scales of satisfac-
tion with life domains and life as a whole.
The life domains covered usually include
work, accommodation, family, social rela-
tions, leisure, safety, finances, and physical
and mental health. The mean score of the
satisfaction ratings – or similar subjective
ratings – is taken as the level of subjective
quality of life (Priebe et al, 1999a).
Patients’ appraisal of their life is influ-
enced by three major processes: a compari-
son with original expectations and
aspirations; a comparison with the life
situation and achievements of others; and
an adaptation over time. The latter two
may be particularly relevant for people
with chronic schizophrenia, whose peer
group is often people with similar impair-
ments, and who may adapt to circum-
stances that they might have found
unsatisfactory many years earlier. As a
result, people with persistent disorders
who often live in conditions that seem
adversarial and unpleasant to clinicians
and observers, nevertheless express relative
satisfaction with their life (Arns & Linney,
1993; Awad et al, 1997; Katschnig et al,
1997; Priebe et al, 1999b).
Correlations between objective and
subjective indicators are reported to be
weak to moderate (ranging from 0.04 to
0.57; Priebe & Fakhoury, 2007). The low
association between objective life situation
and patients’ subjective appraisal has often
been counterintuitive to clinicians and
other observers, who subsequently ques-
tioned the validity of patient ratings. Yet,
if patients are asked to give a subjective ap-
praisal of their situation and express a high
satisfaction with how they live, there is
hardly any external criterion based on
which such an appraisal may be disquali-
fied. Thus, patients’ views and satisfaction
ratings may look surprising to the indepen-
dent observer, but need to be respected as
subjective indicators.
Assessment instruments
A range of scales, checklists and structured
and semi-structured interviews have been
developed to assess quality of life in people
with schizophrenia. The results of scales
assessing symptom levels, particularly of
depression, have been repeatedly reported
as quality of life scores, although the scales
have been developed neither to assess qual-
ity of life nor to capture objective and sub-
jective indicators. These proxy measures
will not be considered here. Table 1 shows
a number of established scales that have
been specifically developed to assess quality
of life and have been used in people with
schizophrenia. The listed assessment instru-
ments for quality of life – and later social
functioning – were identified through a
non-systematic and non-exhaustive litera-
ture search and were selected on the basis
of their use in research.
To assess quality of life in people with
schizophrenia, generic, health-related and
disease-specific instruments can be used.
Generic scales can be applied to the general
population and any group of people with
health problems, including schizophrenia.
Scales often include questions on physical
and mental health, but these are not specific
to any illness or treatment. Results can be
compared across groups with different
characteristics and disorders, irrespective
of the type of intervention received. Exam-
ples are the Quality of Life Interview (QLI;
Lehman, 1983), the Lancashire Quality of
Life Profile (LQOLP; Oliver, 1991) and
the Manchester Short Assessment of
Quality of Life (MANSA; Priebe et al,
1999a).
Health-related quality of life measures
are targeted to assess the quality of life of
samples with health problems irrespective
of the type of illness and interventions. Ex-
amples are the Medical Outcome Study
Questionnaire (MOS), which was modified
and shortened to the 36-item Short-Form
General Health Survey (SF–36; Ware &
Sherbourne, 1992), and the EuroQOL–5D
(EQ–5D; EuroQol Group, 1990).
There are also disease-specific mea-
sures, and several of these have been de-
signed to assess the quality of life of
people with schizophrenia. A widely used
disease-specific instrument is the Quality
of Life Scale (QLS; Heinrichs et al, 1984),
which is a clinician rating scale with ac-
ceptable psychometric properties. It was
developed to assess symptom levels and
functional status of people with schizo-
phrenia in longitudinal studies and trials.
Other, less widely used examples of
disease-specific scales are the Subjective
Well-being under Neuroleptics Scale
(SWN; Naber, 1995) and the Schizophrenia
Quality of Life Scale (SQLS; Wilkinson et
al, 2000). These scales tend to capture
symptoms, in particular mood symptoms,
and side-effects of antipsychotic medi-
cation. Although they may be important
in influencing quality of life, the labelling
of these factors as quality of life is question-
able and can blur the concept. It might be
preferable to measure symptoms as symp-
toms and side-effects as side-effects, instead
of declaring them to be a direct indicator of
quality of life.
There are differences in the use of the
scales worldwide. In the USA, the QLS,
QLI and the Oregon Quality of Life Scale
(OQLS; Bigelow et al, 1991) have been
more widely used, whereas in Europe the
LQOLP, the MANSA and the EQ–5D are
more popular. The previous use of an in-
strument and the availability of data for
comparison are powerful determinants of
the choice of instrument. Other deter-
minants are the time to complete the instru-
ment, the requirements for training, the
properties of the instrument, its overall ap-
proach and exact content, and the purpose
of the data collection.
Properties of instruments
With respect to instrument properties, the




characteristics such as validity, reliability
and objectivity. Yet, these terms are based
on psychological test theory and the as-
sumption that there is a well-defined con-
struct that needs to be measured. In the
assessment of social outcomes, one might
argue that there is no well-defined concept
and psychological test theory does not ap-
ply. Are social outcomes tested or are they
simply assessed and documented? In the lat-
ter case, assessment tools are methods to
document objective indicators and patient
statements. The results on each question
can – unlike in psychological test theory –
be directly interpreted. Items can be sum-
marised in scores, but the score does not ne-
cessarily reflect an underlying construct. To
be administered usefully in longitudinal as-
sessments, scales still need to have certain
qualities, such as providing stable results
over time in the absence of changes in the
person’s social situation. Yet, this would
not be a conventional test–retest reliability
because there is no construct to be ‘tested’.
This is a theoretical debate which, however,
is important for interpreting results of
social outcome measures, and should be
addressed in the future development of
new instruments.
SOCIAL FUNCTIONING
After quality of life, social functioning of
people with schizophrenia has received the
most extensive attention in the psychiatric
literature. Instruments assessing social
functioning capture the capacity of a person
to function in different societal roles and
their actual social performance. Table 2
shows instruments to assess social function-
ing in people with schizophrenia.
As in quality of life assessment, the
selection of an instrument depends on
various factors, and an ideal scale for all
purposes does not exist.
EMPIRICAL FINDINGS
The literature on social outcomes in general
in people with schizophrenia and on their
quality of life specifically is vast. Some
results cast light on the strengths and weak-
nesses of social outcomes, in particular
subjective indicators.
Subjective quality of life is less favour-
able in people with schizophrenia who are
younger, male, live alone or are homeless,
have a high level of education and are not
employed (Lehman et al, 1995; Priebe et
al, 1998; Priebe & Fakhoury, 2007). Yet,
these characteristics explain only a small
amount of the variance of subjective quality
of life scores in clinical samples. The most
consistent and relevant factor influencing
subjective quality of life in people with
schizophrenia is the level of psychopatholo-
gical symptoms, in particular mood. The
more depressed a person is the lower the
subjective quality of life. This applies to
both cross-sectional and longitudinal
associations (Kaiser et al, 1997; Priebe et
al, 2000). The causality of the association,
however, is not straightforward. Depres-
sion may lead to a negative appraisal of life,
and, vice versa, a negative experience of the
life situation may lead to depression. Also,
both depression and negative appraisal
may be symptoms of the same underlying
cognitive and affective processes. In any
case, an assessment of subjective indicators
of social outcomes needs to control for
mood as a potential confounding factor.
Social outcomes have been used widely
to evaluate the effects of different treatment
methods in schizophrenia. Although pro-
grammes aimed at improving the social
situation directly, such as vocational rehab-
ilitation and discharge from long-term
hospitalisation (Priebe et al, 2002), can
have a substantial effect, such an impact
has only rarely been demonstrated for
established pharmacological and psycho-
therapeutic interventions (Corrigan et al,
2003; Wiersma et al, 2004).
CONCLUSIONS
Social outcomes have a high intuitive ap-
peal and are called for by different stake-
holder groups, including the public and
user organisations. However, established
scales to assess social outcomes lack a
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Client Quality of Life Interview CQLI Mulkern et al (1986) 65 8
EuroQOL^5D EQ^5D EuroQol Group (1990) 15 5
Index of Health Related Quality of Life Not defined Rosser et al (1992) 107, 225 3
Lancashire Quality of Life Profile LQOLP Oliver (1991) 100 11
Manchester Short Assessment of Quality of Life MANSA Priebe et al (1999a) 25 12
Munich Quality of Life Dimensions List MLDL Heinisch et al (1991) 20 4
Oregon Quality of Life Scale OQLS Bigelow et al (1991) 146 14
Quality of Life Checklist QLC Malm et al (1981) 93 11
Quality of Life Interview QLI Lehman (1983) 143 8
Quality of Life Scale QLS Heinrichs et al (1984) 21 21
Satisfaction with Life Domains Scale SLDS Baker & Intagliata (1982) 15 15
Schizophrenia Quality of Life Scale SQLS Wilkinson et al (2000) 30 3
Smithkline BeechamQuality of Life SBQOL Dunbar et al (1992) 78 23
SubjectiveWell-being under Neuroleptics Scale SWN Naber (1995) 38 5
Well-Being Project Client Interview Not defined Campbell et al (1989) 151, 76 and 77 60
World Health Organization Quality of Life Instrument ^ Brief WHOQOL^BREF World Health Organization Quality
of Life Group (1998)
268 4
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theoretical model, are not based on univer-
sally agreed definitions, focus on a limited
number of aspects and, subsequently, often
lead to disappointment. The distinction
between objective and subjective indicators
appears to be essential. With respect to
objective indicators, any routine documen-
tation and trial should assess whether
people have work, how they live, and
whether they have social contacts. Future
research might benefit from a consistent de-
finition of the categories used so that find-
ings can be compared and benchmarked
across studies and services. Statistical ana-
lyses would be helped by a method to
synthesise different aspects of the objective
living situation into one overall index.
The spectrum of measures to assess
subjective indicators of social outcomes is
huge and growing every year. Some con-
cepts, most notably subjective quality of life
and social functioning, have been exten-
sively used in schizophrenia research, yield-
ing data for comparison and specific
findings of interest. Their strengths and
weaknesses have been well documented.
On balance, they should be used to assess
outcome and capture the central view of
the patients concerned. To use them appro-
priately, there are at least three require-
ments: (a) whoever uses such concepts
should be aware of the limitations and have
a good understanding of what the selected
instrument actually assesses, independent
of the title of the scale; the contents of
scales need to be considered along with
practical aspects, when the best instrument
for the given purpose is selected; (b) it is
difficult to justify the use of more than
one instrument to assess subjective indica-
tors of social outcomes in the same study;
what the scales assess is conceptually not
distinct, and scores of different instruments
overlap (Fakhoury et al, 2002); (c) symp-
tom levels, and in particular mood, need to
be assessed and controlled for in any analysis
of patient ratings of social outcomes.
Rather than taking new appealing
terms and pragmatically developing scales
to assess them, future work on improving
assessment tools should be based on
defined theoretical models and take the
existing empirical findings into account.
Within psychiatry, schizophrenia re-
search has led in the development of meth-
ods to assess social outcomes. It is widely
seen as mandatory to assess social out-
comes in epidemiological studies and clini-
cal trials. The literature provides sufficient
evidence for the use of assessment instru-
ments and appropriate interpretation of
the results. Yet, despite several decades of
research, more needs to be done to specify
the concepts and develop better assessment
instruments. This requires approaches that
are qualitatively new, and not just more
of the same.
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